Ariad Pharmaceuticals Inc fka ARIA

[risk on]

Ariad's hard reality, it's bad, "On October 9, 2013, Ariad disclosed that one of its products, a last-line treatment for certain types of chronic myeloid leukemia, had demonstrated higher than expected rates of blood clots and related health problems. Two days later, the FDA announced that it was investigating life-threatening blood clots and narrowing of blood vessels in patients using the medication. On October 18, 2013, the Company agreed to terminate a trial of the drug. On October 31, 2013, the Company disclosed that it would suspend sales of the drug. "

Real bad, and it gets worse.

11 Law Firms investigating or filing Legal action for Ariads actions of suppressing the truth of the drugs trial suspension per an agreement w the FDA. ( all documented in public record of legal allegations recently filed)